Connection

John Wharton to Middle Aged

This is a "connection" page, showing publications John Wharton has written about Middle Aged.
Connection Strength

0.096
  1. Cardiac Computed Tomography for Atrial Fibrillation Patients Undergoing Ablation: Implications for the Prediction of Early Recurrence. J Thorac Imaging. 2020 May; 35(3):186-192.
    View in: PubMed
    Score: 0.013
  2. Effect of increased parasympathetic and sympathetic tone on internal atrial defibrillation thresholds in humans. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):238-42.
    View in: PubMed
    Score: 0.012
  3. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration. Circulation. 1997 Mar 18; 95(6):1487-96.
    View in: PubMed
    Score: 0.010
  4. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion. J Cardiovasc Transl Res. 2013 Aug; 6(4):528-35.
    View in: PubMed
    Score: 0.008
  5. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
    View in: PubMed
    Score: 0.007
  6. Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
    View in: PubMed
    Score: 0.006
  7. Transient reversal of bifascicular block during acute myocardial infarction with reperfusion therapy: a word of caution. Am Heart J. 1989 Jun; 117(6):1381-3.
    View in: PubMed
    Score: 0.006
  8. The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
    View in: PubMed
    Score: 0.006
  9. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.006
  10. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol. 2006 Feb 15; 97(4):532-7.
    View in: PubMed
    Score: 0.005
  11. Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004 Feb 24; 109(7):828-32.
    View in: PubMed
    Score: 0.004
  12. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J Am Coll Cardiol. 2000 Jun; 35(7):1905-14.
    View in: PubMed
    Score: 0.003
  13. Concealed mechanical bradycardia: an indication for permanent pacemaker implantation. Pacing Clin Electrophysiol. 1998 Oct; 21(10):2007-8.
    View in: PubMed
    Score: 0.003
  14. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. Pacing Clin Electrophysiol. 1997 Mar; 20(3 Pt 1):624-30.
    View in: PubMed
    Score: 0.003
  15. Radiofrequency ablation of atrial flutter and atrial tachycardias in patients with permanent indwelling catheters. Pacing Clin Electrophysiol. 1996 Nov; 19(11 Pt 1):1612-7.
    View in: PubMed
    Score: 0.002
  16. Syncope secondary to paroxysmal high grade AV block in a heavily trained man. Pacing Clin Electrophysiol. 1991 Jun; 14(6):994-9.
    View in: PubMed
    Score: 0.002
  17. Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry. Pacing Clin Electrophysiol. 1990 Jun; 13(6):705-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.